Purchased shares and warrants in the September 2024 underwritten public offering
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Shao-Lee Lin
Also a director
Chief Executive Officer
Title from the Form 4 dated Oct 12, 2026
|
Not stated | Not stated | Not reported | |
|
James Ahlers
Chief Financial Officer
Title from the Form 8-K dated Jul 30, 2026
|
Not stated | Not stated | Not reported | |
|
Daniel G. Baker
Interim Chief Development Officer
|
75 |
Since 2024
2 years
|
Not reported | |
|
Sumita Ray
Chief Legal Compliance Officer
Title from the Form 4 dated Oct 12, 2026
|
Not stated | Not stated | Not reported | |
|
Dominique Christian Borie
Chief Medical Officer
Title from the Form 4 dated Jul 13, 2026
|
Not stated | Not stated | Not reported | |
|
Colin G. Sandercock
Senior Vice President, Intellectual Property
|
69 | Not stated | $599,222 | |
|
Michael Meluzio
VP, Prin. Accounting Officer
Title from the Form 4 dated Oct 12, 2026
|
Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Mar 16, 2026 · updated by the 8-Ks of May 1, 2026 and Jun 2, 2026
| Director | Age | On board | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|
|
Pasha Sarraf
Board chair
|
56 |
2025
1 year
|
None stated | PolarityBio, Praesidia Biotherapeutics | $88,080 | |
|
Shao-Lee Lin
Joined Apr 30, 2026
CEO
|
- | - | - | - | Paid as CEO | |
|
Pamela D. Garzone
|
71 |
2023
3 years
|
Compensation Committee
|
None stated | $69,381 | |
|
Daniel Camardo
Joined May 30, 2026
|
- | - |
Nominating and Corporate Governance Committee · Chair
Audit Committee
|
- | - | |
|
Viola Meehan
Joined May 30, 2026
|
- | - |
Audit Committee · Chair
Compensation Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Purchased shares and warrants in the September 2024 underwritten public offering
Purchased shares and warrants in the April 2025 underwritten public offering
Purchased warrants in the December 2025 underwritten public offering
Loading...